As per the latest report by IMARC Group, titled “Scar Treatment Market Report by Product or Treatment Type (Topical Products, Laser Treatment, Surface Treatment, Injectables), Scar Type (Atrophic Scars, Hypertrophic and Keloid Scars, Contracture Scars, and Others), End-User (Hospitals, Clinics, Retail Pharmacies, and Others), and Region 2025-2033,” the global scar treatment market size reached USD 16.6 Billion in 2024. Scars are inevitable results of wounds or surgeries that appear different in color and texture from the surrounding healthy tissues. In order to minimize and eliminate their appearance, scar treatment is widely utilized as a remedy for acne, keloid, contracture and hypertrophic scars. Nowadays, various therapies are used for speeding up the healing process, which include over the counter (OTC) gels, creams, ointments, silicone sheets, surgeries for skin grafts, excisions or laser treatment and collagen injections.
Global Scar Treatment Market Trends:
Owing to the growing competition, distributors of scar treatment solutions across the globe are focusing on reducing product prices to retain a competitive edge in the market. Moreover, owing to the rising penetration of the internet and the thriving e-commerce sector, they are promoting their products through online media. Numerous social media platforms, such as blogs and social discussion websites, are posting reviews of these products, which is further contributing to their popularity worldwide. Furthermore, the market for scar treatment is driven by the growing prevalence of skin diseases, such as vitiligo, psoriasis, eczema, and photoaging of the skin, and increasing appearance consciousness among consumers. Besides this, improving accessibility to dermatological facilities and the easy availability of products manufactured using both chemical and herbal ingredients are anticipated to strengthen the market growth in the coming years. Dermatological clinics generally offer precise and latest technological procedures for cosmetic surgeries that provide effective results and cause minimal discomfort to the patients. Looking forward, the market value is projected to reach USD 30.7 Billion by 2033, expanding at a CAGR of 6.72% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product or Treatment Type, Scar Type, End-User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates |
Companies Covered | Alliance Pharma PLC, AVITA Medical Ltd., Bausch Health Companies Inc., Cutera, Inc., Establishment Labs SA, GC Aesthetics PLC, Hologic Inc., Mölnlycke Health Care AB, Smith & Nephew PLC and Sonoma Pharmaceuticals Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
Phone No: (D) +91 120 433 0800 | www.imarcgroup.com
Americas :- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163